TY  - GEN
AU  - Calle-Jiménez, Olivia de la
AU  - Casado-Fernández, Guiomar
AU  - Armenteros-Yeguas, Inés
AU  - Lemus-Aguilar, Luis
AU  - Baza, Begoña
AU  - Pérez-García, Jorge Alfredo
AU  - Rodríguez-Añover, Javier
AU  - Mateos, Elena
AU  - Homen, Reynaldo
AU  - Orviz-García, Eva
AU  - Cabello, Noemí
AU  - Negredo, Anabel
AU  - Sánchez-Seco, María Paz
AU  - Del Romero, Jorge
AU  - Estrada, Vicente
AU  - Torres, Montserrat
AU  - Coiras, Mayte
PY  - 2025
DO  - 10.1002/jmv.70498
UR  - https://hdl.handle.net/20.500.12105/27314
AB  - In August 2024, the World Health Organization declared mpox infection a Public Health Emergency of International Concern for second time since 2022 and recommended vaccinating all people at-risk, such as people with HIV-1 (PWH) and prophylaxis...
LA  - eng
PB  - Wiley
KW  - CD4 + T cells
KW  - CD8 + T cells
KW  - HIV‐1
KW  - MPXV
KW  - PrEP
KW  - MPOX
KW  - AIDS Vaccines
KW  - Adult
KW  - CD4-Positive T-Lymphocytes
KW  - CD8-Positive T-Lymphocytes
KW  - Female
KW  - HIV Infections
KW  - HIV-1
KW  - Humans
KW  - Immunity, Cellular
KW  - Injections, Subcutaneous
KW  - Interferon-gamma
KW  - Interleukin-2
KW  - Male
KW  - Middle Aged
KW  - Pre-Exposure Prophylaxis
KW  - Vaccination
KW  - Young Adult
TI  - Low Specific T-Cell Immunity Against Mpox Elicited in People With HIV-1 and PrEP Users After Subcutaneous Vaccination Compared to Natural Infection.
TY  - research article
ER  -